Abstract

Lorazepam 2-mg Sublingual Tablets

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2003 - Terrorism

Page(s): 138

Download in electronic PDF format for $75

Abstract

A formulation for preparing Lorazepam 2-mg Sublingual Tablets. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2003 Pg. 138	Lorazepam 2-mg Sublingual Tablets Author(s): Allen Loyd V Jr
May/Jun 2003 Pg. 219	Ergotamine Tartrate 2-mg Sublingual Tablets Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Mar/Apr 2003 Pg. 134	Lorazepam 2-mg Gelatin Troches Author(s): Allen Loyd V Jr
Mar/Apr 2003 Pg. 134	Lorazepam 2-mg Polyethlene Glycol Troches Author(s): Allen Loyd V Jr
Jul/Aug 2002 Pg. 300	Estriol 2-mg and Estradiol 0.5-mg/0.1-mL Sublingual Drops Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 148-155	Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets Author(s): Mahesparan Vishnu A/L, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai
Mar/Apr 2022 Pg. 163-174	Molding as Innovative Technology for Personalized Tablet Production Author(s): Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
May/Jun 2023 Pg. 240-249	An Alternative Approach to Tablet Splitting and Grinding for Medication Administration Author(s): Taneja Rajneesh, Scarim Joseph, Pande Poonam G, Scarim Anthony, Nahata Milap C, Jew Rita K, Inabathina Koteswara Rao
Mar/Apr 2022 Pg. 143	Lorazepam 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 319	Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 317	Lorazepam 1 mg/mL in Anhydrous Organic Solvent System Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 420	Lorazepam 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 161	Lorazepam 4-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2003 Pg. 233-239	Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Author(s): Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
Nov/Dec 2020 Pg. 509-514	Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract Author(s): Azman Syahiera Ezzah Noor, Abd Razak Fashli Syafiq, Kamal Wan Hamirul Bahrin Wan, Zheng Gan Kok, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Mar/Apr 2020 Pg. 168-175	Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
May/Jun 2022 Pg. 255-263	Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Author(s): Liew Kai Bin, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
Sep/Oct 2022 Pg. 370-377	Recent Formulation Advances and Preparation of Orally Disintegrating Tablets Author(s): Ejeta Fikadu